Zenas Biopharma's Purchased 60,000: Insider Buy Deep Dive
A biotech CEO just bought a sizable chunk of his company’s stock. That move sparks questions about conviction, risk, ...
Choosing the right credit card for cash back can boost your savings. Explore options that deliver the best return on your spending.
25,914 articlesA biotech CEO just bought a sizable chunk of his company’s stock. That move sparks questions about conviction, risk, ...
A fresh review finds that a $10,000 investment in rsp’s equal-weight trap: $10,000 lagged a cap-weighted S&P 500 fund...
TG Therapeutics faces a pivotal year as it closes 2025 with a tighter focus on its flagship therapeutics portfolio an...
A viral post about a person earning $36k a year with $136k in debt and a prize horse has lawmakers and financiers wei...
Investors are increasingly choosing self-made cash flow over waiting for an inheritance. A dividend-focused portfolio...
In 2026, four Dividend Kings are outperforming the S&P 500 as investors pivot to cash-flow creators. The move signals...
River Road Asset Management just added a notable new position in AptarGroup, acquiring 917,670 shares valued at about...
As AI deployment accelerates, investors are racing into energy stocks, naming a cluster of seven top names the munifi...
A seasoned investing plan shows ordinary savers can generate $5,000 per month in passive income through dividend stra...
ExxonMobil is not just drilling and refining anymore. This article explores how the company might evolve toward a bro...
In his first shareholder letter, Berkshire Hathaway’s new leader pledges continuity, a robust balance sheet, and read...
A large fund snapped up 1.2 million Vir Biotechnology shares as the stock doubled this past year. Here’s how to read ...